Search

Your search keyword '"Kufner, Sebastian"' showing total 182 results

Search Constraints

Start Over You searched for: Author "Kufner, Sebastian" Remove constraint Author: "Kufner, Sebastian" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
182 results on '"Kufner, Sebastian"'

Search Results

1. Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel

5. Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial

9. Periprocedural myocardial injury according to optical characteristics of neointima and treatment modality of in-stent restenosis

11. Trombosis del stent 10 años después de la intervención coronaria percutánea con stents nuevos frente a stents de la primera generación. Observaciones del metanálisis DECADE

12. Índice de masa corporal y eficacia y seguridad del ticagrelor frente al prasugrel en pacientes con síndrome coronario agudo

14. Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors.

19. Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes

20. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk

22. Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromes

23. Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors

24. Recurrent Revascularization at 10 Years after Percutaneous Treatment of Drug-Eluting Stent Restenosis

25. Ten‐year outcomes after percutaneous coronary intervention of in‐stent restenosis in saphenous vein grafts

26. Correlaci�n fluorosc�pica y tomogr�fica para medir el anillo a�rtico en implante percut�neo de v�lvula a�rtica: regla de c�spide coronaria derecha

27. Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation

28. Fluoroscopic and tomographic correlation for aortic annulus measurements in transcatheter aortic valve implantation: �follow the right cusp� rule

30. Derivation and validation of the ISAR score to predict the risk of repeat percutaneous coronary intervention for recurrent drug-eluting stent restenosis

31. Correlación fluoroscópica y tomográfica para medir el anillo aórtico en implante percutáneo de válvula aórtica: regla de cúspide coronaria derecha

32. Langzeitverlauf von Patienten mit koronarer Herzerkrankung: Vergleich der klinischen Ergebnisse dreier medikamentenfreisetzender Stents zehn Jahre nach perkutaner Intervention

33. Very long-term outlook of acute coronary syndromes after percutaneous coronary intervention with implantation of polymer-free versus durable-polymer new-generation drug-eluting stents.

35. Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial

36. Machine learning identifies pathophysiologically and prognostically informative phenotypes among patients with mitral regurgitation undergoing transcatheter edge-to-edge repair

38. Ten-year clinical outcomes of drug-eluting stents with different polymer coating strategies by degree of coronary calcification: a pooled analysis of the ISAR-TEST 4 and 5 randomised trials

40. Iliofemoral artery predilation prior to transfemoral transcatheter aortic valve implantation in patients with aortic valve stenosis and advanced peripheral artery disease

41. Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial

42. Association between Platelet Count and Treatment Effect of Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

43. The effect of a Prasugrel- vs. a Ticagrelor-based strategy on total ischaemic and bleeding events in patients with acute coronary syndromes

44. Ten-year patterns of stent thrombosis after percutaneous coronary intervention with new- versus early-generation drug-eluting stents: insights from the DECADE cooperation

45. Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes

46. Rotational Atherectomy or Balloon-Based Techniques to Prepare Severely Calcified Coronary Lesions

48. Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy

49. Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial

50. Diabetes mellitus and femoropopliteal in-stent restenosis

Catalog

Books, media, physical & digital resources